Media stories about Align Technology (NASDAQ:ALGN) have been trending somewhat positive on Tuesday, Accern Sentiment Analysis reports. The research firm identifies negative and positive media coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Align Technology earned a daily sentiment score of 0.15 on Accern’s scale. Accern also assigned news coverage about the medical equipment provider an impact score of 46.6424358681927 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.

Here are some of the news articles that may have impacted Accern Sentiment’s rankings:

Shares of Align Technology (ALGN) traded up $4.36 during midday trading on Tuesday, hitting $223.12. The stock had a trading volume of 1,155,100 shares, compared to its average volume of 1,025,840. Align Technology has a twelve month low of $88.56 and a twelve month high of $266.41. The stock has a market capitalization of $17,889.25, a price-to-earnings ratio of 67.61, a price-to-earnings-growth ratio of 2.13 and a beta of 1.43.

Align Technology (NASDAQ:ALGN) last announced its earnings results on Thursday, October 26th. The medical equipment provider reported $1.01 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.82 by $0.19. The business had revenue of $385.30 million for the quarter, compared to analyst estimates of $359.80 million. Align Technology had a return on equity of 25.60% and a net margin of 19.98%. The company’s revenue for the quarter was up 38.3% compared to the same quarter last year. During the same period in the previous year, the company earned $0.63 earnings per share. equities research analysts predict that Align Technology will post 3.62 earnings per share for the current fiscal year.

Several equities analysts have weighed in on ALGN shares. Piper Jaffray Companies reissued a “buy” rating and set a $200.00 price target on shares of Align Technology in a research report on Monday, September 11th. Robert W. Baird restated a “buy” rating on shares of Align Technology in a report on Tuesday, September 12th. Goldman Sachs Group raised their price objective on Align Technology from $185.00 to $210.00 and gave the stock a “buy” rating in a report on Friday, September 15th. Morgan Stanley restated an “overweight” rating and set a $220.00 price objective (up previously from $195.00) on shares of Align Technology in a report on Friday, October 6th. Finally, Northcoast Research restated a “buy” rating and set a $230.00 price objective (up previously from $200.00) on shares of Align Technology in a report on Tuesday, October 10th. One equities research analyst has rated the stock with a hold rating and eleven have assigned a buy rating to the company’s stock. Align Technology currently has a consensus rating of “Buy” and an average target price of $236.75.

In other Align Technology news, CFO John Morici sold 1,500 shares of Align Technology stock in a transaction that occurred on Friday, November 24th. The stock was sold at an average price of $255.00, for a total value of $382,500.00. Following the completion of the transaction, the chief financial officer now directly owns 1,544 shares in the company, valued at $393,720. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CMO Raphael Pascaud sold 5,400 shares of Align Technology stock in a transaction that occurred on Friday, November 3rd. The shares were sold at an average price of $241.88, for a total value of $1,306,152.00. Following the completion of the transaction, the chief marketing officer now owns 22,228 shares of the company’s stock, valued at $5,376,508.64. The disclosure for this sale can be found here. Over the last three months, insiders sold 52,849 shares of company stock valued at $13,494,348. 1.60% of the stock is owned by corporate insiders.

COPYRIGHT VIOLATION WARNING: “Somewhat Favorable Media Coverage Somewhat Unlikely to Impact Align Technology (ALGN) Share Price” was originally reported by Watch List News and is owned by of Watch List News. If you are accessing this article on another website, it was illegally stolen and republished in violation of U.S. and international copyright law. The legal version of this article can be viewed at https://www.watchlistnews.com/somewhat-favorable-media-coverage-somewhat-unlikely-to-impact-align-technology-algn-share-price/1783838.html.

About Align Technology

Align Technology, Inc designs, manufactures and markets a system of clear aligner therapy, intra-oral scanners and computer-aided design/computer-aided manufacturing (CAD/CAM) digital services used in dentistry, orthodontics and dental records storage. The Company operates through two segments: Clear Aligner segment and Scanner and Services (Scanner) segment.

Insider Buying and Selling by Quarter for Align Technology (NASDAQ:ALGN)

Receive News & Ratings for Align Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Align Technology and related companies with MarketBeat.com's FREE daily email newsletter.